Geocann, Colorado-based CBD company, announced in a press release that is now launching its first cannagierol (CBG) softgel formulas that utilize the VESlsorb delivery system. This type of approach works to promote bioavailability and better absorption. The initial formulation combines CBD and CBG, while the second is a mono-CBG formulation.
Marc Weder shared in a press release,
“These product launches further advance Geocann’s leadership position as product development specialists that provide science-backed solutions to the industry’s formulation challenges. The marketplace is demanding advancements beyond just CBD products and we are supremely positioned to deliver these solutions with more than three decades of research and product development expertise.”
“Geocann has accomplished these results and has successfully transferred a rigorous product development protocol to the large-scale commercial production of soft gel capsules, topicals, foods, beverages, and sublinguals that combine these active ingredients with the VESIsorb® technology.”
Jesse Lopez, the CEO and founder added,
“The combination of CBD, CBG, and BCP powered by VESIsorb® in an elegant soft gel capsule is an important industry milestone. Geocann will continue to pioneer the advancement of new cannabinoids, like CBG, CBN, and THCV, as it’s a privilege to offer these first-to-market opportunities to our brand partners.”